Everi Stock Forecast, Price & News

Everi (NYSE:EVRI) Frequently Asked Questions

Is Everi a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Everi in the last twelve months. There are currently 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Everi stock.
View analyst ratings for Everi or view top-rated stocks.

What stocks does MarketBeat like better than Everi?

Wall Street analysts have given Everi a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Everi wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Everi's next earnings date?

Everi is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for Everi.

How were Everi's earnings last quarter?

Everi Holdings Inc. (NYSE:EVRI) released its quarterly earnings data on Wednesday, August, 4th. The credit services provider reported $0.36 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.32 by $0.04. The credit services provider had revenue of $172.58 million for the quarter, compared to analysts' expectations of $168.86 million. Everi had a trailing twelve-month return on equity of 440.82% and a net margin of 10.49%.
View Everi's earnings history.

How has Everi's stock price been impacted by COVID-19?

Everi's stock was trading at $6.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EVRI shares have increased by 254.5% and is now trading at $24.57.
View which stocks have been most impacted by COVID-19.

What guidance has Everi issued on next quarter's earnings?

Everi issued an update on its FY 2021 earnings guidance on Wednesday, August, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $615 million-$635 million, compared to the consensus revenue estimate of $607.85 million.

What price target have analysts set for EVRI?

8 analysts have issued twelve-month price targets for Everi's stock. Their forecasts range from $19.00 to $39.00. On average, they expect Everi's share price to reach $25.88 in the next year. This suggests a possible upside of 5.3% from the stock's current price.
View analysts' price targets for Everi or view top-rated stocks among Wall Street analysts.

Who are Everi's key executives?

Everi's management team includes the following people:

• Michael David Rumbolz, Chairman & Chief Executive Officer
• Randy L Taylor, President & Chief Operating Officer
• Mark F. Labay, Chief Financial Officer, Treasurer & Executive VP
• Richard P. Hallman, Chief Information Officer & Executive VP
• Kate C. Lowenhar-Fisher, Secretary, Chief Legal Officer, Executive VP

What is Michael D. Rumbolz's approval rating as Everi's CEO?

75 employees have rated Everi CEO Michael D. Rumbolz on Glassdoor.com. Michael D. Rumbolz has an approval rating of 84% among Everi's employees.

Who are some of Everi's key competitors?

Some companies that are related to Everi include Visa (V), Mastercard (MA), Automatic Data Processing (ADP), Fidelity National Information Services (FIS), Fiserv (FISV), Global Payments (GPN), Paychex (PAYX), FLEETCOR Technologies (FLT), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), Genpact (G), The Western Union (WU), WEX (WEX), Euronet Worldwide (EEFT) and Maximus (MMS).
View all of EVRI's competitors.

What other stocks do shareholders of Everi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Everi investors own include Inovio Pharmaceuticals (INO), Matinas BioPharma (MTNB), OrganiGram (OGI), New Residential Investment (NRZ), General Electric (GE), ADMA Biologics (ADMA), Dynavax Technologies (DVAX), Chesapeake Energy (CHKAQ), Sorrento Therapeutics (SRNE) and Nokia (NOK).

What is Everi's stock symbol?

Everi trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVRI."

Who are Everi's major shareholders?

Everi's stock is owned by many different retail and institutional investors. Top institutional investors include Eagle Asset Management Inc. (6.67%), BlackRock Inc. (6.38%), Vanguard Group Inc. (5.87%), Thrivent Financial for Lutherans (4.83%), Thrivent Financial for Lutherans (4.83%) and Invesco Ltd. (3.00%). Company insiders that own Everi stock include Darren Simmons, David Lucchese, Dean A Ehrlich, Eileen F Raney, Geoffrey P Judge, Harper H Ko, Linster W Fox, Mark F Labay, Maureen T Mullarkey, Michael D Rumbolz, Randy L Taylor and Todd A Valli.
View institutional ownership trends for Everi.

Which institutional investors are selling Everi stock?

EVRI stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Millennium Management LLC, Renaissance Technologies LLC, BlackRock Inc., Clearbridge Investments LLC, Eagle Asset Management Inc., DG Capital Management LLC, and Silvercrest Asset Management Group LLC. Company insiders that have sold Everi company stock in the last year include Darren Simmons, David Lucchese, Dean A Ehrlich, Eileen F Raney, Geoffrey P Judge, Linster W Fox, Mark F Labay, Michael D Rumbolz, Randy L Taylor, and Todd A Valli.
View insider buying and selling activity for Everi or view top insider-selling stocks.

Which institutional investors are buying Everi stock?

EVRI stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Vaughan Nelson Investment Management L.P., Simcoe Capital Management LLC, Vanguard Group Inc., Fuller & Thaler Asset Management Inc., Federated Hermes Inc., Castleark Management LLC, and Putnam Investments LLC. Company insiders that have bought Everi stock in the last two years include David Lucchese, Harper H Ko, and Maureen T Mullarkey.
View insider buying and selling activity for Everi or or view top insider-buying stocks.

How do I buy shares of Everi?

Shares of EVRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Everi's stock price today?

One share of EVRI stock can currently be purchased for approximately $24.57.

How much money does Everi make?

Everi has a market capitalization of $2.21 billion and generates $383.67 million in revenue each year. The credit services provider earns $-81,680,000.00 in net income (profit) each year or ($0.89) on an earnings per share basis.

How many employees does Everi have?

Everi employs 1,300 workers across the globe.

What is Everi's official website?

The official website for Everi is www.everi.com.

Where are Everi's headquarters?

Everi is headquartered at 7250 S. Tenaya Way Suite 100, Las Vegas NV, 89113.

How can I contact Everi?

Everi's mailing address is 7250 S. Tenaya Way Suite 100, Las Vegas NV, 89113. The credit services provider can be reached via phone at (800) 833-7110 or via email at [email protected].